You are here
Study Evaluating PSI-697 in Patients With Scleritis
About this Study
To evaluate the safety of an orally administered single dose of PSI-697 in subjects with
scleritis, as a model of inflammatory disease. To evaluate by in vivo confocal microscopy
(IVCM) the effect of a single dose of PSI-697 on leukocyte rolling in the scleral blood
vessels of subjects with scleritis.